Picture of Abbott Laboratories logo

ABT — Abbott Laboratories Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+10.25%
3m+3.63%
6m+6.08%
1yr+1.09%
Volume Change (%)
10d/3m+12.81%
Price vs... (%)
52w High-20.94%
50d MA-3.63%
200d MA-9.17%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)23.12
PEG Ratio (f)2.15
EPS Growth (f)12.03%
Dividend Yield (f)1.67%
Valuation (ttm)IndustryMarket
Price to Book Value5.58
Price to Tang. Bookn/a
Price to Free Cashflow24.22
Price to Sales4.43
EV to EBITDA16.32

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital15.04%
Return on Equity22.4%
Operating Margin20.73%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue$m27,39030,57831,90434,60843,07541,727.6441,050.0415.61%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+60.87+28.2+40.34+17.68+61.46+21.01-0.04n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for ABT

Will the Abbott Laboratories share price run continue? background image

Will the Abbott Laboratories share price run continue?

In this article we will quickly re-cap the broker forecasts for Abbott Laboratories (NYQ:ABT). The Abbott Laboratories share price has risen by 1.98% over the past month and it’s currently trading at 104.16. For investors considering w...

The Abbott Laboratories share price – where next? background image

The Abbott Laboratories share price – where next?

The Abbott Laboratories (NYQ:ABT) share price has risen by 2.86% over the past month and it’s currently trading at 94.92. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will...

Brokers bullish on Abbott Laboratories shares background image

Brokers bullish on Abbott Laboratories shares

The Abbott Laboratories (NYQ:ABT) share price has risen by 10.3% over the past month and it’s currently trading at 93.7. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Abbott Laboratories EPS forecast chart

Profile Summary

Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.

Directors

Last Annual
December 31st, 2021
Last Interim
March 31st, 2022
Incorporated
March 6th, 1900
Public Since
March 1st, 1937
No. of Shareholders
35,926
No. of Employees
113,000
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
1,750,942,289

ABT Share Price Performance

Similar to ABT

Picture of Agilent Technologies logo

Agilent Technologies

us flag iconNew York Stock Exchange

Picture of Agiliti logo

Agiliti

us flag iconNew York Stock Exchange

Picture of Alcon AG logo

Alcon AG

us flag iconNew York Stock Exchange

Picture of AmerisourceBergen logo

AmerisourceBergen

us flag iconNew York Stock Exchange

Picture of Artivion logo

Artivion

us flag iconNew York Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email